Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC (Q104793322)
Jump to navigation
Jump to search
scientific article published on 07 January 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC |
scientific article published on 07 January 2021 |
Statements
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC (English)
Naoki Niikura
Kosuke Kashiwabara
Takeshi Amemiya
Ken-Ichi Watanabe
Hironobu Hata
Yuichiro Kikawa
Naoki Taniike
Takashi Yamanaka
Sachiyo Mitsunaga
Kazuhiko Nakagami
Moriyasu Adachi
Naoto Kondo
Yasuyuki Shibuya
Naoki Hayashi
Toshinari Yamashita
Masahiro Umeda
Hirofumi Mukai
Yoshihide Ota
7 January 2021